Furthermore, additional research conducted by Li and colleagues on three GI cancer genomics datasets uncovered that ARID1A‐mutated GI cancers with elevated immune activity were associated with higher TMB and lower levels of tumour aneuploidy.62 Here, ARID1A is linked to neoplasm.